Elizabeth Robinson

Brembo leads the world in the design and production of high-performance braking systems and components for top-flight manufacturers of cars, motorbikes and commercial vehicles. Founded in 1961 in Italy, Brembo has a long-standing reputation for providing innovative solutions for OEMs and aftermarket. Brembo also competes in the most challenging motorsport championships in the world and has won over 600 titles. Guided by its strategic vision – “Turning Energy into Inspiration” – Brembo’s ambition is to help shape the future of mobility through cutting-edge, digital and sustainable solutions. With over 15,600 people across 15 countries, 32 production and business sites, 9 R&D centers and with a turnover of € 3,849 million in 2023, Brembo is the trusted solution provider for everyone who demands the best driving experience.

Italian Friends of TCF – The Citizens Foundation è un’associazione italiana senza scopo di lucro, ONLUS riconosciuta , che sostiene The Citizens Foundation – TCF, l’organismo non-profit pakistano che dal 1995 costruisce e gestisce scuole per bambini e bambine svantaggiati del Pakistan. Le scuole di TCF offrono un’istruzione laica, moderna e di alta qualità e ad un costo accessibile per le famiglie economicamente deboli del Pakistan. Italian Friends of TCF intende far conoscere in Italia il complesso e delicato lavoro svolto da TCF come anche gli aspetti dell’accesso scolastico in Pakistan, con particolare attenzione all’istruzione femminile, sensibilizzando sul tema e promuovendo azioni di solidarietà a sostegno di TCF. L’associazione, nata formalmente nel marzo 2013, è attiva in Italia già dal 2010 grazie all’impegno di un gruppo di donne spinte dalla motivazione di aiutare le bambine del Pakistan ad andare a scuola e ricevere una formazione di qualità affinché abbiano anche loro la possibilità di diventare agenti attive di quel “positive change” in cui i fondatori di TCF credono fermamente per il proprio paese.

Brembo leads the world in the design and production of high-performance braking systems and components for top-flight manufacturers of cars, motorbikes and commercial vehicles. Founded in 1961 in Italy, Brembo has a long-standing reputation for providing innovative solutions for OEMs and aftermarket. Brembo also competes in the most challenging motorsport championships in the world and has won over 600 titles. Guided by its strategic vision – “Turning Energy into Inspiration” – Brembo’s ambition is to help shape the future of mobility through cutting-edge, digital and sustainable solutions. With over 15,600 people across 15 countries, 32 production and business sites, 9 R&D centers and with a turnover of € 3,849 million in 2023, Brembo is the trusted solution provider for everyone who demands the best driving experience.

Founded in 2016, today Indaco Venture Partners SGR is the largest independent Italian venture capital asset management company, with a strong specialization in companies that innovate in electronics and robotics, medtech, digital and new materials. Indaco manages over 250 million across its five funds. Investments in Indaco Ventures Fund I are focused on growth-stage companies whose competitive advantage stems from cutting-edge proprietary technologies and innovations. In terms of teams and technologies, the focus is on Italian enterprises, although investments are made throughout Europe, USA, Canada and Israel. Anchor institutional investors in Indaco Ventures Fund I include Intesa Sanpaolo, Fondazione Cariplo and Fondo Italiano d’Investimento. In the digital sector, Indaco has an advisory partnership with growITup. The investment team managers have more than 10 years of experience in venture investing in Italy and abroad and have executed a high number of successful exits, including IPOs and transactions with corporate partners.

MolMed S.p.A. is a clinical stage biotech company focused on research, development, manufacturing and clinical validation of innovative therapies. MolMed's product portfolio includes proprietary anti-tumor therapies in both clinical and preclinical development, both autologous and allogeneic. Zalmoxis® (TK) is a cell therapy based on donor T cells genetically engineered to enable bone marrow transplants from partially compatible donors for patients with high-risk hematological malignancies, eliminating post-transplant immunosuppression prophylaxis and inducing a rapid immune reconstitution. Zalmoxis®, that received orphan drug designation, is currently in Phase III, but has already obtained a Conditional Marketing Authorization by the EU Commission in the 2nd half of 2016 as well as reimbursement conditions in Italy and in Germany at the beginning of 2018. Still focusing on this cell & gene technology, MolMed is developing a new therapeutic platform based on Chimeric Antigen Receptor (CAR), both autologous and allogeneic; the most advanced product, CAR-T CD44v6, received in March 2019 the authorization to start human clinical trials in onco-hematologic indications (AML and MM) , following an extensive pre-clinical phase; the product is potentially effective also in several epithelial solid tumors. With regards to allogeneic CARs, MolMed is developing a pipeline based on NK (Natural Killer) cells, following a research agreement signed in 2018 with Glycostem. MolMed is also the first company in Europe to have obtained the GMP manufacturing authorization for cell & gene therapies for its proprietary products (Zalmoxis) as well as for third parties and/or in partnership (Strimvelis, an Orchard gene therapy for the ADA-SCID). With reference to GMP development and manufacturing activities for third parties, MolMed signed numerous partnership agreements with leading European and US companies. MolMed is listed on the MTA of Borsa Italiana since 2008.

Italian Friends of TCF – The Citizens Foundation è un’associazione italiana senza scopo di lucro, ONLUS riconosciuta , che sostiene The Citizens Foundation – TCF, l’organismo non-profit pakistano che dal 1995 costruisce e gestisce scuole per bambini e bambine svantaggiati del Pakistan. Le scuole di TCF offrono un’istruzione laica, moderna e di alta qualità e ad un costo accessibile per le famiglie economicamente deboli del Pakistan. Italian Friends of TCF intende far conoscere in Italia il complesso e delicato lavoro svolto da TCF come anche gli aspetti dell’accesso scolastico in Pakistan, con particolare attenzione all’istruzione femminile, sensibilizzando sul tema e promuovendo azioni di solidarietà a sostegno di TCF. L’associazione, nata formalmente nel marzo 2013, è attiva in Italia già dal 2010 grazie all’impegno di un gruppo di donne spinte dalla motivazione di aiutare le bambine del Pakistan ad andare a scuola e ricevere una formazione di qualità affinché abbiano anche loro la possibilità di diventare agenti attive di quel “positive change” in cui i fondatori di TCF credono fermamente per il proprio paese.